Linked Life Data

19321732

Source:http://linkedlifedata.com/resource/pubmed/id/19321732

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19321732rdf:typepubmed:Citationlld:pubmed
pubmed-article:19321732lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C0205466lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C1706515lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C0005528lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C1704640lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C1516698lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:19321732lifeskim:mentionsumls-concept:C0331858lld:lifeskim
pubmed-article:19321732pubmed:issue5lld:pubmed
pubmed-article:19321732pubmed:dateCreated2009-4-30lld:pubmed
pubmed-article:19321732pubmed:abstractTextA novel method for the collection and transportation of dried-blood-plasma samples, SampleTanker (ST), was developed and compared to standard shipping protocols for frozen-plasma specimens containing human immunodeficiency virus type 1 (HIV-1) and/or hepatitis C virus (HCV). Matched frozen and dried 1-ml EDTA-containing plasma samples were collected and analyzed by several molecular-based virologic assays. After addition of 1.175 ml of reconstitution buffer, 1.035 ml of dried plasma was recovered. Mean intra-assay variances were 0.05, 0.05, and 0.06 log(10) copies/ml for the Versant, Amplicor, and NucliSens QT HIV-1 load assays, respectively (P, not significant). However, mean HIV-1 viral load was consistently reduced in dried samples by 0.32 to 0.51 log(10) copies/ml, depending on assay type (P < 0.05). Infectious HIV-1 was not recovered from dried ST plasma. There was no significant difference in HIV-1 viral load results obtained using ST after 8 weeks of storage at ambient temperature. Compared to frozen plasma, HIV-1 genotypic results were >99% concordant at the nucleotide and amino acid levels, as well as for resistance-associated mutations. We further demonstrated successful detection of multiple analytes, including HIV-1 viral load, HIV-1 antiretroviral resistance genotype, and HCV genotype, from a single ST unit. Dried plasma collected with ST yielded comparable results to frozen samples for multiple-analyte clinical testing. As such, ST could be a useful alternative for virologic tests and clinical trials worldwide by significantly diminishing transportation cost and the sample volume restrictions associated with dried-blood-spot technology.lld:pubmed
pubmed-article:19321732pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:languageenglld:pubmed
pubmed-article:19321732pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19321732pubmed:citationSubsetIMlld:pubmed
pubmed-article:19321732pubmed:statusMEDLINElld:pubmed
pubmed-article:19321732pubmed:monthMaylld:pubmed
pubmed-article:19321732pubmed:issn1098-660Xlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:TannerMMlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:FeorinoP MPMlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:BurnsD ADAlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:ArmstrongWWlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:WintersM AMAlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:TsukagoshiMMlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:HolodniyMMlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:Yen-Lieberman...lld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:TaegeAAlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:MathisR LRLlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:McClernonD...lld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:De La RosaAAlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:HuongJ TJTlld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:FergusonMoniq...lld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:O'BrienWillia...lld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:WetshteinJ...lld:pubmed
pubmed-article:19321732pubmed:authorpubmed-author:FriedrichBria...lld:pubmed
pubmed-article:19321732pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19321732pubmed:volume47lld:pubmed
pubmed-article:19321732pubmed:ownerNLMlld:pubmed
pubmed-article:19321732pubmed:authorsCompleteYlld:pubmed
pubmed-article:19321732pubmed:pagination1491-6lld:pubmed
pubmed-article:19321732pubmed:dateRevised2011-4-21lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:meshHeadingpubmed-meshheading:19321732...lld:pubmed
pubmed-article:19321732pubmed:year2009lld:pubmed
pubmed-article:19321732pubmed:articleTitleDried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing.lld:pubmed
pubmed-article:19321732pubmed:affiliationResearch Think Tank, Inc., Buford, Georgia, USA.lld:pubmed
pubmed-article:19321732pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19321732pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:19321732pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:19321732pubmed:publicationTypeEvaluation Studieslld:pubmed